Login / Signup

The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2.

Atul DeodharDafna D GladmanRebecca BolceDavid SandovalSo Young ParkSoyi Liu LeagePeter NashDenis Poddubnyy
Published in: Therapeutic advances in musculoskeletal disease (2023)
IXE is effective in improving axial symptoms in patients with active PsA presenting with axial manifestations.
Keyphrases
  • phase iii
  • clinical trial
  • open label
  • phase ii
  • prostate cancer
  • case report
  • physical activity
  • randomized controlled trial
  • radical prostatectomy
  • sleep quality